Is repeat fine needle aspiration required in thyroid nodules with initial benign cytology? Results from a large Irish series

• Published in: BMC endocrine disorders Vol. 22; no. 1; p. 102
• Main Authors: Zia-Ul-Hussnain, Hafiz M, Kgosidialwa, Oratile, Kennedy, Carmel, Quinn, Mark, Dolan, Emma, Deignan, Paul, Sherlock, Mark, Thompson, Chris J, Smith, Diarmuid, O'Neill, James P, Hill, Arnold, Leader, Mary, Barrett, Helen, Ryan, Cliona, Keeling, Frank, Morrin, Martina M, Agha, Amar
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 15.04.2022; BioMed Central; BMC
• Subjects: Benign; Biopsy; Biopsy, Fine-Needle - methods; Cellular biology; Classification; Cytology; Decision making; Female; Fine needle aspiration; Humans; Immunoassay; Male; Malignancy; Middle Aged; Nodules; Pathology; Patients; Radiation; Retrospective Studies; Thy classification; Thyroid; Thyroid cancer; Thyroid diseases; Thyroid Neoplasms - diagnostic imaging; Thyroid Neoplasms - epidemiology; Thyroid nodule; Thyroid Nodule - diagnostic imaging; Thyroid Nodule - epidemiology; Ultrasonic imaging; Thy classification; Thyroid nodule; Benign; Fine needle aspiration
• ISSN: 1472-6823; 1472-6823
• DOI: 10.1186/s12902-022-01014-6

BACKGROUND : Fine needle aspiration (FNA) cytology is the preferred method for assessing thyroid nodules for malignancy. Concern remains about the rate of false negative results. The primary aim of this study is to investigate the malignancy rate of thyroid nodules initially classified as benign (Thy 2). We retrospectively examined 658 nodules in 653 (429 female) patients between January 2013 to December 2017. All FNA biopsies (FNABs) were performed under ultrasound (US) guidance by a radiologist with expertise in thyroid pathology. Nodules were cytologically classified according to the UK Royal College of Pathologists guidelines. Decisions about further management were made at a regular thyroid multidisciplinary meeting. Follow up of the Thy 2 nodules was determined based on clinical and radiological criteria. The mean age (± SD) was 53.2 (14.6) years. Five hundred out of 658 (76.0%) nodules were classified as Thy 2 (benign) after the first FNAB. Of these thyroid nodules initially classified as benign, 208 (41.6%) underwent repeat FNAB and 9 (1.8%) were surgically removed without repeat FNAB. The remainder were followed up clinically and/or radiologically. Seven (1.4%) of nodules initially classified as Thy 2 were later shown to be or to harbor malignancy after a follow-up of 74.5 (± 19.7) months. Papillary thyroid microcarcinomas were found co-incidentally in two thyroid glands of benign nodules, giving a true prevalence of 5/500 (1.0%). With a well targeted FNAB, the false negative rate of an initial benign thyroid FNA is very low thus routine second FNAB is not required in patients with a thyroid nodule initially deemed benign. Multidisciplinary input is imperative in informing decision making.